Publications | UCSF Philip R. Lee Institute for Health Policy Studies

Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease.

Whittington MD, Campbell JD, Rind D, Fluetsch N, Lin GA, Pearson SD

Neurology 2022 Mar doi: 10.1212/WNL.0000000000013314

Assessing the quality of evidence in studies estimating prevalence of exposure to occupational risk factors: The QoE-SPEO approach applied in the systematic reviews from the WHO/ILO Joint Estimates of the Work-related burden of disease and Injury.

Pega F, Momen NC, Gagliardi D, Bero LA, Boccuni F, Chartres N, Descatha A, Dzhambov AM, Godderis L, Loney T, Mandrioli D, Modenese A, van der Molen HF, Morgan RL, Neupane S, Pachito D, Paulo MS, Prakash KC, Scheepers PTJ, Teixeira L, Tenkate T, Woodruff TJ, Norris SL

Environ Int 2022 Mar doi: 10.1016/j.envint.2022.107136

The role of policy and law in shaping the ethics and quality of end-of-life care in intensive care.

Dzeng E, Bein T, Curtis JR

Intensive Care Med 2022 Mar doi: 10.1007/s00134-022-06623-2

Differential misclassification of cognitive impairment by sex among hip fracture patients.

Mutchie HL, Albrecht JS, Orwig DL, Huang Y, Boscardin WJ, Hochberg MC, Magaziner JS, Gruber-Baldini AL

J Am Geriatr Soc 2022 Mar doi: 10.1111/jgs.17594

The Triple Bottom Line and Stabilization Wedges: A Framework for Perioperative Sustainability.

By: Choi BJJ, Chen CL

Anesth Analg 2022 Mar doi: 10.1213/ANE.0000000000005890

Content Analysis of Transportation Screening Questions in Social Risk Assessment Tools: Are We Capturing Transportation Insecurity?

Razon N, Gottlieb L